4.5 Article

Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics

Andrea Sottoriva et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Oncology

Prognostic significance of MRP5 immunohistochemical expression in glioblastoma

George A. Alexiou et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)

Article Gastroenterology & Hepatology

DFMO: Targeted risk reduction therapy for colorectal neoplasia

Christina M. Laukaitis et al.

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)

Article Biochemistry & Molecular Biology

PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation

J-J Lee et al.

CELL DEATH AND DIFFERENTIATION (2011)

Review Clinical Neurology

Review: On TRAIL for malignant glioma therapy?

J. M. A. Kuijlen et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2010)

Article Oncology

Polyamine depletion induces G1 and S phase arrest in human retinoblastoma Y79 cells

Akiko Ueda et al.

Cancer Cell International (2008)

Article Oncology

The effect of DFMO induced uptake of [3H] putrescine on human glioma cells

ES Redgate et al.

JOURNAL OF NEURO-ONCOLOGY (2001)

Article Biochemistry & Molecular Biology

Ionizing radiation can overcome resistance to TRAIL in TRAIL-resistant cancer cells

MR Kim et al.

FEBS LETTERS (2001)